TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Trabecular Bone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perineal pain at day 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preventing severe oral mucositis (OM)
Endpoint domain: Mortality/survival
Primary endpoint: Preventing interruptions in radiotherapy (RT) due to OM
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Worsening of oral health-related quality of life (OHRQoL)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: MS risk increase per standard deviation of BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T2DM risk
Endpoint domain: Mortality/survival
Primary endpoint: 3-year event rate
Endpoint domain: Mortality/survival
Primary endpoint: Total scores for HAMA, HAMD, SAS, and SDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with efficacy index (EI) > 1 for CGIS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of treatment based on TCM syndrome scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Usability scores
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Completion of goals
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Participant's adherence levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall symptom improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average penile curvature after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Erection score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased functionality
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Range of motion for hip extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-controlled fentanyl requirements
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time needed to control blood glucose <13.8 mmol/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Amount of insulin needed to control blood glucose <13.8 mmol/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Self-care behaviors
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: DSQ and GOHAI scores improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of cases requiring denture adjustments
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Changes in spherical equivalent refraction (SE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in axial length (AL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of grade C AL
Endpoint domain: Adverse events/effects
Primary endpoint: Spontaneous closure of grade A or B AL
Endpoint domain: Adverse events/effects
Primary endpoint: willingness to repeat the procedure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: annualized attack rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serious treatment‐emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Absolute risk difference (ARD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Durability of response after 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: USSQ-body pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite of all-cause death, non-fatal myocardial infarction, non-fatal stroke, and unstable angina pectoris
Endpoint domain: Mortality/survival
Primary endpoint: working memory performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Physical well-being in girls
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Activation of hamstrings during concentric contractions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: symptom management knowledge score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: symptoms self‐management knowledge score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: intraoperative remifentanil consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative cumulative opioid consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early satiety/postprandial fullness (ES/PPF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Non-opioid analgesic requirement in days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: morphine consumption during the first 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: morphine consumption during the first 72 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prediction of LVI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of port site wound infection
Endpoint domain: Adverse events/effects
Primary endpoint: Risk for OSA measured by SBQ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: slower reaction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: worse visual memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: levels of bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of follow-up modalities
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety and tolerability of MEDI5884
Endpoint domain: Adverse events/effects
Primary endpoint: combined pathologic complete response or minimum residual disease rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day mortality rate after major amputation
Endpoint domain: Mortality/survival
Primary endpoint: self-rated symptoms of depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: state and trait anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage average of hair loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentrations of 17‐OH‐progesterone, androstenedione, testosterone, and estradiol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Expression levels of CYP19a1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Knowledge about physical activity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-efficacy to exercise
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Scar size (0.1 cm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: health motivation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Body–food choice congruence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Unconditional permission to eat
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Occurrence of Atrial Fibrillation (AF)
Endpoint domain: Mortality/survival
Primary endpoint: first recurrent AF within 90 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Colour misperception of red signals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seedling emergence percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emergence speed index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Root and shoot dry mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in meat intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in red and processed meat intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum intact parathyroid hormone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Implementation of pain management protocols
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite Clinical Success score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in post‐treatment global cognition
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Pain scores (NRS scores)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: male partner HST uptake
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Changes in glycated hemoglobin (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of complications related to EAC reconstruction
Endpoint domain: Adverse events/effects
Primary endpoint: Average postoperative Air-Bone Gap
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to ventilation (TTV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for vasoactive support
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total opioid exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numeric Rating Scale (NRS) score at rest and during coughing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: first major bleeding event
Endpoint domain: Adverse events/effects
Primary endpoint: LATCH scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transition time to full breastfeeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean heart rate of infants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time needed for hemostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dialysis adequacy (spKt/V)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intubation within 72 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Moderate to severe nasal trauma
Endpoint domain: Adverse events/effects
Primary endpoint: area-under-glucose-curve values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: insulin/glucose incremental area under the curves
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Income level
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: trans- and post-operative pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: need for post-operative analgesia
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: femoral cartilage thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neuromuscular control of the deep cervical flexors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neuromuscular capacity of scapulothoracic muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in PD and RAL scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in GCF TAOC levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of pethidine or epidural analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: post-procedural bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Restorations intact
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leicester Cough Questionnaire score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: expired carbon monoxide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urine N‐acetyl‐S‐(3‐hydroxypropyl)‐L‐cysteine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of total adverse drug reactions (ADRs)
Endpoint domain: Adverse events/effects
Primary endpoint: IgG antibodies to S-protein and RBD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroconversion rates for S-protein or RBD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroconversion rates for MN50
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: MPOD mean and MPOD max values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RNFL and GCL++ measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean intraocular pressure values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: upper body strength parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: flexibility gains
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of EC skin test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of EC skin test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Educational attainment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Substance use disorders
Endpoint domain: Adverse events/effects
Primary endpoint: Negative emotionality
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: NAC mobility sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: annualised exacerbation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: severe hypoglycaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean percent change in volume and area of scars
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Dirt removal rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuropathic Pain Symptom Inventory total scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brief Pain Inventory interference scale total
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patients’ Global Impression of Change scale scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of intervention and trial-related processes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of patients experiencing gastrointestinal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction in serum levels and expression of IL-17 mRNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: self-contamination in the arm/hand area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Reduction of pain in response to air stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intention to conduct sun protective behaviours
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: amount of fluid intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: nursing hours
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: N-back cognitive performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Pain and symptom impact
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: desire for a comprehensive tool for future planning
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Neutrophil content in BAL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Oxygenation (PaO2:FiO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Days on invasive mechanical ventilation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: self-reported externalizing behaviors
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Accuracy on incongruent trials of the modified attention network task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Prostate-specific androgen progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: burst suppression burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration from epidural analgesia to baby delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Verbal numerical rate scaling score in low back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consumption of ropivacaine per hour
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: NRS of foreign body sensation at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NRS of numbness at 1 month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: advanced fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: intubation task time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: contentment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Disruptive behavior improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: haemoglobin at discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in risk of CID
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in CID in FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived CID in health status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: NT-proBNP geometric mean reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardiac troponin I (cTnI) geometric mean reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Intervention satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived therapeutic alliance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: total cognitive score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: mental status
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: words recall
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: VRS-swelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VRS-willingness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maternal underweight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Risk of albumin progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Proportion of infants receiving iNO
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postnatal age at iNO initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of iNO therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of HIVE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Motor deficits
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Impaired brain growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mental Component Summary (MCS) response-shift effects
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Systemic interleukin 6 (IL‐6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction of pain sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Increment of physical activity level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increment of quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Seroconversion rate against S1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric mean concentration of S1 antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: L1-L4 BMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and lymphatic system outcomes
Primary endpoint: Streptococcus bacterial count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes